Table 3. Indication for valproate for women included in the first and last quarters of the study period.
| Valproateindicationa | Dataextraction from 1 Oct 2017 | Data extraction from 1 Jan 2020 |
|---|---|---|
| n (%) | n (%) | |
| Epilepsy | 139 (65) | 88 (65) |
| Bipolar disorder | 31 (14) | 20 (15) |
| Migraine | 4 (2) | 2 (1) |
| Learning difficulties | 5 (2) | 5 (4) |
| Other or unknown | 35 (16) | 21 (15) |
| Total patients | 214 (100) | 136 (100) |
aLikely indication inferred from recorded long-term conditions on electronic health record.